MAZE
Maze Therapeutics, Inc. · Healthcare
President, R&D & CMO Harold Bernstein sold $255K of Maze Therapeutics, Inc.
Sold$254,502
$26.22Price
9,705Shares
−100%Stake
What MAZE did after the filing
- The stock from Wed, Sep 9 open, $25.86
- +0.7%
- S&P 500, same days
- +1.0%
12 of 30 trading days so far, to the Sep 25 close.
Traded Fri, Sep 4. Filed Tue, Sep 8, 4:20 PM ET, after the close. Returns use the Sep 9 open and the Sep 25 close. Not investment advice.